Jun-yi Ye

Fatal cases of human infection with avian influenza A (H7N9) virus in Shanghai, China in 2013.

Hongzhou Lu, Zhiyong Zhang, Yinzhong Shen, 2015, Bioscience trends.

Concomitant genetic alterations having greater impact on the clinical benefit of EGFR‐TKIs in EGFR‐mutant advanced NSCLC than BIM deletion polymorphism

Yi-long Wu, Jin-Ji Yang, Xuchao Zhang, 2020, Clinical and translational medicine.

Clinical Utility of Cerebrospinal Fluid Cell‐Free DNA as Liquid Biopsy for Leptomeningeal Metastases in ALK‐Rearranged NSCLC

Yi-long Wu, Jin-Ji Yang, S. Chuai, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Clinical characteristics and prognostic value of the KRAS G12C mutation in Chinese non-small cell lung cancer patients

Yi-long Wu, Jin-Ji Yang, Y. Shao, 2020, Biomarker Research.

Epidermal growth factor receptor inhibitors as adjuvant treatment for patients with resected non-small cell lung cancer harboring EGFR mutation: a meta-analysis of randomized controlled clinical trials

W. Feng, N. Zhao, Jun-yi Ye, 2023, World Journal of Surgical Oncology.

RAD18 polymorphisms are associated with platinum-based chemotherapy toxicity in Chinese patients with non-small cell lung cancer

B. Han, Rong Li, Jun-yi Ye, 2016, Acta Pharmacologica Sinica.

Analysis of resistance mechanisms to abivertinib, a third-generation EGFR tyrosine kinase inhibitor, in patients with EGFR T790M-positive non-small cell lung cancer from a phase I trial

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2019, EBioMedicine.

Lung Adenocarcinoma Harboring EGFR T790M and In Trans C797S Responds to Combination Therapy of First‐ and Third‐Generation EGFR TKIs and Shifts Allelic Configuration at Resistance

Yi-long Wu, Jin-Ji Yang, Jie Huang, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

The spatiotemporal evolution of EGFR C797S mutation in EGFR-mutant non-small cell lung cancer: opportunities for third-generation EGFR inhibitors re-challenge.

Yi-long Wu, Jin-Ji Yang, Chongrui Xu, 2019, Science bulletin.